Lyka labs Ltd is a pharmaceutical company engaged in development, manufacturing and marketing of pharmaceutical products. It has a well-diversified business model in terms of markets, therapies and products.
It is one of the oldest company in the Indian Pharmaceutical Industry having presence in Domestic and International markets.
Financial Results:
Lyka Labs Ltd reported Revenues for Q1FY24 of ₹22.88 Crores down from ₹27.49 Crore year on year, a fall of 16.77%.
Total Expenses for Q1FY24 of ₹25.06 Crores down from ₹27.68 Crores year on year, a fall of 9.47%.
Consolidated Net Profit of -₹1.85 Crores from ₹0.60 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.56, from ₹0.21 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.